...
首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway
【24h】

Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway

机译:血管活性肠肽通过环状单磷酸腺苷蛋白激酶a途径减轻小鼠的肝脏缺血/再灌注损伤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hepatic ischemia/reperfusion injury (IRI), an exogenous, antigen-independent, local inflammation response, occurs in multiple clinical settings, including liver transplantation, hepatic resection, trauma, and shock. The nervous system maintains extensive crosstalk with the immune system through neuropeptide and peptide hormone networks. This study examined the function and therapeutic potential of the vasoactive intestinal peptide (VIP) neuropeptide in a murine model of liver warm ischemia (90 minutes) followed by reperfusion. Liver ischemia/reperfusion (IR) triggered an induction of gene expression of intrinsic VIP; this peaked at 24 hours of reperfusion and coincided with a hepatic self-healing phase. Treatment with the VIP neuropeptide protected livers from IRI; this was evidenced by diminished serum alanine aminotransferase levels and well-preserved tissue architecture and was associated with elevated intracellular cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) signaling. The hepatocellular protection rendered by VIP was accompanied by diminished neutrophil/macrophage infiltration and activation, reduced hepatocyte necrosis/apoptosis, and increased hepatic interleukin-10 (IL-10) expression. Strikingly, PKA inhibition restored liver damage in otherwise IR-resistant VIP-treated mice. In vitro, VIP not only diminished macrophage tumor necrosis factor α/IL-6/IL-12 expression in a PKA-dependent manner but also prevented necrosis/apoptosis in primary mouse hepatocyte cultures. In conclusion, our findings document the importance of VIP neuropeptide-mediated cAMP-PKA signaling in hepatic homeostasis and cytoprotection in vivo. Because the enhancement of neural modulation differentially regulates local inflammation and prevents hepatocyte death, these results provide the rationale for novel approaches to managing liver IRI in transplant patients. Liver Transpl 19:945-956, 2013.
机译:肝缺血/再灌注损伤(IRI)是一种外源性的,非抗原依赖性的局部炎症反应,在多种临床情况下发生,包括肝移植,肝切除,创伤和休克。神经系统通过神经肽和肽激素网络与免疫系统保持广泛的串扰。这项研究检查了小鼠肝炎性缺血(90分钟)再灌注后血管活性肠肽(VIP)神经肽的功能和治疗潜力。肝脏缺血/再灌注(IR)引发内在VIP的基因表达诱导。在再灌注的24小时达到峰值,并与肝的自我修复阶段相吻合。 VIP神经肽治疗可保护肝脏免受IRI;血清丙氨酸氨基转移酶水平降低和组织结构良好保存可以证明这一点,并且与细胞内环状单磷酸腺苷(cAMP)-蛋白激酶A(PKA)信号升高有关。 VIP提供的肝细胞保护作用伴随着嗜中性粒细胞/巨噬细胞浸润和激活减少,肝细胞坏死/凋亡减少以及肝白介素10(IL-10)表达增加。令人惊讶的是,PKA抑制可恢复原本对IR抵抗的VIP治疗小鼠的肝脏损伤。在体外,VIP不仅以PKA依赖的方式减少了巨噬细胞肿瘤坏死因子α/ IL-6 / IL-12的表达,而且还预防了原代小鼠肝细胞培养物中的坏死/凋亡。总之,我们的发现证明了VIP神经肽介导的cAMP-PKA信号在体内肝脏稳态和细胞保护中的重要性。由于神经调节的增强可差异性地调节局部炎症并防止肝细胞死亡,因此这些结果为治疗移植患者肝脏IRI的新方法提供了理论依据。肝运输19:945-956,2013。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号